Comment from florida anit aging center

AnonymousOpposeIndividual
Summary: Dr. Raymond D. Adamcik, a practicing physician at the Florida Anti-Aging Centre, opposes the reclassification of peptides. He argues that peptides are safe and effective for medical and therapeutic uses and expresses concern that reclassification without considering existing clinical evidence could limit patient access to these treatments.
10/11/2023 Food and Drug Administration Office of Regulatory Affairs Dear Sir/Madam, I am writing to express my concerns and provide feedback regarding the reclassification of peptides. I am a practicing physician, Dr. Raymond D. Adamcik MD, associated with the Florida Anti-Aging Centre, and I have had the privilege of working with peptides as part of my anti-aging practice. I would like to emphasize the critical importance of considering the extensive body of evidence supporting the safety and efficacy of peptides in medical and therapeutic applications. It is evident through numerous studies and clinical trials that peptides are, in fact, quite safe and have demonstrated significant benefits in promoting health and well-being. In my years of clinical practice, I have found peptides to be invaluable tools in promoting health, vitality, and overall quality of life for our patients. They have played a pivotal role in our efforts to combat the effects of aging, manage chronic health conditions, and enhance the overall wellness of our patients. The safe and responsible use of peptides has had a profound impact on the lives of many individuals who have sought our services. I strongly believe that reclassifying peptides without due consideration of their safety and efficacy could be a disservice to the patient population. Peptides offer an innovative approach to medical and therapeutic interventions, and they should be accessible to healthcare providers like myself who aim to provide the highest standard of care to our patients. I kindly request that the FDA takes into account the extensive research and clinical evidence available regarding the safe and effective use of peptides. I encourage a thorough and thoughtful evaluation of the potential implications of reclassification on patient access to these valuable tools for improving health and well-being. I appreciate your attention to this matter and would welcome the opportunity to discuss this further or provide additional information if needed. Thank you for your time and consideration. Sincerely, Raymond Adamcik M.D Florida Anti-aging Center Satellite beach, FL 321m 690-0003 Drraya78@gmail.com

View on Regulations.gov